Publications

The electrostatic landscape of MHC-peptide binding revealed using inception networks

April 17th, 2024

View details

Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment

April 1st, 2024

View details

Tsyn-seq: a T cell synapse-based antigen identification platform

March 18th, 2024

View details

Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations

March 15th, 2024

View details

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

March 13th, 2024

View details

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

March 11th, 2024

View details

HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405

March 8th, 2024

View details

Structural basis for self-discrimination by neoantigen-specific TCRs

March 8th, 2024

View details

APE-Gen2.0: Expanding Rapid Class I Peptide-Major Histocompatibility Complex Modeling to Post-Translational Modifications and Noncanonical Peptide Geometries

February 28th, 2024

View details

Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers

February 28th, 2024

View details

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials

February 27th, 2024

View details

An immunogenetic basis for lung cancer risk

February 23rd, 2024

View details

Pan-cancer proteogenomics characterization of tumor immunity

February 14th, 2024

View details

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study

February 6th, 2024

View details

Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention

January 18th, 2024

View details

Contact Info

Publications by BreakBio team members and advisors

The electrostatic landscape of MHC-peptide binding revealed using inception networks

Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment

Tsyn-seq: a T cell synapse-based antigen identification platform

Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405

Structural basis for self-discrimination by neoantigen-specific TCRs

APE-Gen2.0: Expanding Rapid Class I Peptide-Major Histocompatibility Complex Modeling to Post-Translational Modifications and Noncanonical Peptide Geometries

Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials

An immunogenetic basis for lung cancer risk

Pan-cancer proteogenomics characterization of tumor immunity

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study

Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention

Contact

Link

Contact Info

Publications by BreakBio team members and advisors

Discover Our Innovative Cancer Solutions.

Contact

Discover Our Innovative
Cancer Solutions.